Deykin Aaron sold 895 Upstream Bio shares at $5.49 each on Sept. 16, 2026, leaving him with 32,302 shares. The sale represented about 2.7% of his prior Upstream Bio holding, giving investors the disclosed scale of the insider transaction and the remaining ownership position.
Key Highlights
- The Upstream Bio transaction was priced at $5.49 per share.
- Deykin Aaron’s reported ownership after the sale stood at 32,302 shares.
- The transaction represented about 2.7% of Aaron’s prior Upstream Bio holding.
Deykin Aaron sold 895 shares of Upstream Bio (NASDAQ: UPB) at $5.49 per share on Sept. 16, 2026. The transaction left Aaron with 32,302 shares, while the sale represented about 2.7% of his previous holding in Upstream Bio.
Transaction Details and Sale Classification
Aaron is identified as Upstream Bio’s Chief Medical Officer. The reported activity involved 895 Upstream Bio shares changing hands at the stated per-share price. The transaction date was Sept. 16, 2026. Upstream Bio is the company connected to Aaron’s reported share ownership.
FAQs
Q: How much did Deykin Aaron receive per Upstream Bio share sold?
A: Deykin Aaron sold the Upstream Bio shares at $5.49 per share. The transaction involved 895 shares.
Q: How many Upstream Bio shares did Deykin Aaron own after the sale?
A: Aaron held 32,302 Upstream Bio shares after the transaction. He is identified as the company’s Chief Medical Officer.
Q: When did Deykin Aaron sell the Upstream Bio shares?
A: The Upstream Bio insider transaction took place on Sept. 16, 2026.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.